Connection

Cynthia Timmers to MAP Kinase Kinase 1

This is a "connection" page, showing publications Cynthia Timmers has written about MAP Kinase Kinase 1.
Connection Strength

0.271
  1. Trametinib for the treatment of IGHV4-34, MAP2K1-mutant variant hairy cell leukemia. Leuk Lymphoma. 2018 04; 59(4):1008-1011.
    View in: PubMed
    Score: 0.143
  2. Whole-exome tumor sequencing study in biliary cancer patients with a response to MEK inhibitors. Oncotarget. 2016 Feb 02; 7(5):5306-12.
    View in: PubMed
    Score: 0.128
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.